Evidence map›Paper›PMID 25868623›Full record

ReviewMagnetic resonance imaging2015

Interactive Feature Space Explorer© for multi-modal magnetic resonance imaging.

Alpay Özcan, Barış Türkbey, Peter L Choyke, Oguz Akin, Ömer Aras, Seong K Mun

Abstract readReview
In one paragraph

Review in Magnetic resonance imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alpay ÖzcanArlington Innovation Center: Health Research, Virginia Polytechnic Institute and State University, 900 N. Glebe Road, Arlington VA 22203, USA. Electronic address: alpay@vt.edu.
Barış TürkbeyMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr., MSC 1182, Bldg. 10, Rm. 1B40, Bethesda, MD 20892-1088, USA. Electronic address: turkbeyi@mail.nih.gov.
Peter L ChoykeMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr., MSC 1182, Bldg. 10, Rm. 1B40, Bethesda, MD 20892-1088, USA. Electronic address: pchoyke@mail.nih.gov.
Oguz AkinMemorial Sloan Kettering Cancer Center, 1275 York Ave C276, New York, NY 10065, USA. Electronic address: akino@mskcc.org.
Ömer ArasMemorial Sloan Kettering Cancer Center, 1275 York Ave C276, New York, NY 10065, USA. Electronic address: araso@mskcc.org.
Seong K MunArlington Innovation Center: Health Research, Virginia Polytechnic Institute and State University, 900 N. Glebe Road, Arlington VA 22203, USA. Electronic address: munsk@vt.edu.

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
Prostate Cancer ImagingZ01BC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2005 to 2008
$2.1M
Intramural NIH HHS Z01 BC010655Intramural NIH HHS ZIA BC010655
6 · The paper itself

Abstract

Wider information content of multi-modal biomedical imaging is advantageous for detection, diagnosis and prognosis of various pathologies. However, the necessity to evaluate a large number images might hinder these advantages and reduce the efficiency. Herein, a new computer aided approach based on the utilization of feature space (FS) with reduced reliance on multiple image evaluations is proposed for research and routine clinical use. The method introduces the physician experience into the discovery process of FS biomarkers for addressing biological complexity, e.g., disease heterogeneity. This, in turn, elucidates relevant biophysical information which would not be available when automated algorithms are utilized. Accordingly, the prototype platform was designed and built for interactively investigating the features and their corresponding anatomic loci in order to identify pathologic FS regions. While the platform might be potentially beneficial in decision support generally and specifically for evaluating outlier cases, it is also potentially suitable for accurate ground truth determination in FS for algorithm development. Initial assessments conducted on two different pathologies from two different institutions provided valuable biophysical perspective. Investigations of the prostate magnetic resonance imaging data resulted in locating a potential aggressiveness biomarker in prostate cancer. Preliminary findings on renal cell carcinoma imaging data demonstrated potential for characterization of disease subtypes in the FS.

Indexed as

AlgorithmsHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleMultimodal ImagingProstateProstatic NeoplasmsCancer imagingComputer-aided detection and diagnosisMulti-modal imagingMulti-parametric imagingProstate cancerRenal cancer

Identifiers

PMID25868623
PMCPMC4458231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.